Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR202506900439697Not yet recruiting
Randomised, open-label trial in Fibromyoma (LM) comparing Tranexamic acid group with Misoprostol group (2 arms). Primary endpoint: Mean intra-operative blood loss. Planned start Jul 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR202506900439697.